Tuesday, July 28, 2026 | 07:04 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
Sensex(    %)
                             
Nifty(    %)
                             
Nifty Midcap(    %)
                             
Nifty Smallcap(    %)
                             
Nifty Bank(    %)
                             
Nifty IT(    %)
                             
Home / Markets / Lupin Ltd / Announcements / BSE

Lupin Ltd

Lupin Limited - Press Release

12:00 AM, 8th May 2025

Lupin Limited has informed the Exchange regarding a press release dated May 08, 2025, titled Lupin Receives Approval from U.S. FDA for Raltegravir Tablets USP, 600 mg.